Cargando…
The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era
Autores principales: | Franco-Paredes, Carlos, Rodriguez-Morales, Alfonso J, Henao-Martínez, Andrés F, Carrasco, Peter, Tuells, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381021/ https://www.ncbi.nlm.nih.gov/pubmed/35985345 http://dx.doi.org/10.1016/S1473-3099(22)00548-5 |
Ejemplares similares
-
Comment to “Recurrent Glioblastoma Treated with Recombinant Poliovirus”
por: Wang, Peng, et al.
Publicado: (2018) -
Assessing the effectiveness of COVID-19 vaccines in older people in Latin America
por: Rodriguez-Morales, Alfonso J, et al.
Publicado: (2022) -
Alloimmunization against Fy3 is a serious threat in the era of cell therapy
por: Lemaire, Baptiste, et al.
Publicado: (2022) -
Vaccine-derived polio in Peru after 32 years of elimination: reflections on the routine childhood immunisation coverages
por: Al-kassab-Córdova, Ali, et al.
Publicado: (2023) -
SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
por: Thiruvengadam, Ramachandran, et al.
Publicado: (2022)